The Brighterside of News on MSN

FDA-approved drug may slow brain cell death in Alzheimer’s patients

Long before memory problems appear, your brain may already be losing neurons. That is the unsettling message from new work by ...
Becker's Spine Review

Spine implants, tech earning FDA nods in 2025

Here are 40 spine devices and technologies earning FDA clearances in 2025. Note: This is not an exhaustive list. 1. SurGenTec earned FDA 510(k) clearance for its OsteoFlo HydroFiber to be used as a ...
Medscape

Should The FDA Require “Clinical Licensure” of AI Tools For Doctors?

A new proposal in JAMA Internal Medicine suggests that the FDA should create an approval pathway for medical AI tools that parallels how physicians are trained and licensed.

Ultragenyx Pharmaceutical Inc.: Ultragenyx Completes Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for Glycogen Storage ...

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) ...
The Manila Times

Ultragenyx Completes Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDI…

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics ...
Healio

FDA approves Deseyne daily disposable extended depth of focus contact lens for presbyopia

The FDA has approved Deseyne contact lenses with extended depth of focus for the correction of presbyopia, according to a ...

Switching from finasteride to dutasteride for hair loss? Here’s what to expect

Research supports that both finasteride and dutasteride help treat hair loss, particularly when caused by androgenetic ...
The Manila Times

Best Weight Loss Pills for 2026? FDA Approves First Oral GLP-1 as Patients Evaluate Wegovy, Zepbound, and Telehealth Access Pathways

Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...

The miracle cure for sickle cell is now 2 years old. Most are still waiting.

Despite a Trump administration push, there are few facilities offering the complex treatment in the rural areas where many ...

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to RegulationsSAN DIEGO, Dec. 26, 2025 (GLOBE NEWSWIRE) -- As the post-holiday period brings ...

Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / December 26, 2025 / RedChip Companies will air interviews with Processa Pharmaceuticals, Inc.

Federal push to relax marijuana classification should help the industry in Illinois. But the effects for consumers may take time.

The new proposed federal classification of marijuana would allow more research, and would let cannabis businesses take normal ...